Enzo Biochem (ENZ) Tops Q3 EPS by 1c

Enzo Biochem (NYSE: ENZ) reported Q3 EPS of ($0.05), $0.01 better than the analyst estimate of ($0.06). Revenue for the quarter came in at $18.16 million versus the consensus estimate of $24.5 million.

For earnings history and earnings-related data on Enzo Biochem (ENZ) click here.

You May Also Be Interested In

• Oracle reports earnings today: AI spending bet faces its toughest test yet
• Diamondrock Hospitality (DRH) PT Raised to $13.50 at Stifel
• MasterCraft (MCFT) Tops Q4 EPS by 3c, Beats on Revenue; Offers Guidance